Christopher Heery, CHIEF MEDICAL OFFICER at Arcellx, Inc. (ACLX), sold 39,268 shares at $60.39 ($2.4M) on 2024-08-01, disclosed to the SEC on 2024-08-02.
Scheduled sale ($2.4M) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.39 | 19,268 | $1.2M | 49.1% |
| 2 | $60.39 | 19,268 | $1.2M | 49.1% |
| 3 | $61.13 | 732 | $45K | 1.9% |
| Total | $60.40 avg | 39,268 | $2.4M | 100% |
| Filing → |
| ACLX | SELL | 2026-01-12 | $393K | — | Filing → |
| ACLX | SELL | 2025-11-17 | $31K | — | Filing → |
| ACLX | SELL | 2025-09-30 | $2.9M | — | Filing → |